Parkinson's Disease
Conference Coverage
Standard Assessments May Miss Psychotic Symptoms in Patients With Parkinson’s Disease
VANCOUVER—Standard clinical assessments of Parkinson’s disease psychosis may miss more than half of psychotic symptoms, according to research...
FDA/CDC
Extended-release amantadine approved for treatment of dyskinesia in Parkinson’s
This is the first FDA approval for a drug to treat levodopa therapy-related dyskinesia in patients with Parkinson’s disease.
Conference Coverage
What New Therapies for Parkinson’s Disease Are on the Horizon?
HILTON HEAD, SC—Many new treatments for Parkinson’s disease are in the pipeline, according to a lecture given at the 40th Annual Contemporary...
Conference Coverage
How to Keep Pace With Genetic Advances in Movement Disorders
VANCOUVER—Researchers’ understanding of genetic causes of movement disorders is advancing rapidly. “The ability to generate data has almost...
Conference Coverage
Spinal Cord Stimulation May Improve Gait in Patients With Advanced Parkinson’s Disease
VANCOUVER—Spinal cord stimulation improves gait in patients with advanced Parkinson’s disease, according to a pilot study described at the 21st...
Literature Review
Light Therapy May Treat Excessive Daytime Sleepiness in Parkinson’s Disease
Light therapy may reduce excessive daytime sleepiness and improve sleep quality in patients with Parkinson’s disease, according to trial results...
Literature Review
New Tool Can Distinguish Between Tremor Syndromes
A new tool called the tremor stability index (TSI) can aid the differential diagnosis of essential tremor and Parkinson’s disease, according to...
Conference Coverage
Inhaled Levodopa Treats Off Periods in Phase III Trial
VANCOUVER—Inhaled levodopa significantly improves motor function during off periods in patients with Parkinson’s disease, according to phase III...
Conference Coverage
Can Cannabis Help Patients With Parkinson’s Disease?
VANCOUVER—Anecdotal reports, patient surveys, and studies have suggested that cannabis may help treat motor and nonmotor symptoms of Parkinson’s...
Conference Coverage
Apomorphine pump dramatically decreases ‘off’ time in Parkinson’s
BOSTON – The degree of improvement has proved to be clinically relevant.
Video
Mandar Jog, MD
Dr. Jog describes a pilot study that assessed the therapeutic effect of spinal cord stimulation on gait dysfunction in patients with advanced...